UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine
Moderna and UNICEF today announced that they have signed a long-term agreement for the supply of COVID-19 ...
Read moreModerna and UNICEF today announced that they have signed a long-term agreement for the supply of COVID-19 ...
Read moreNew agreement with Lonza will increase drug substance production in Europe by the fourth quarter 2021 Lonza Geleen ...
Read moreModerna, Inc. announced that it has entered into an agreement with Thermo Fisher Scientific for fill/finish sterile ...
Read moreModerna, Inc. today announced that it has initiated the rolling submission process with the U.S. Food and ...
Read morePrimary endpoint of non-inferior immunogenicity versus the Phase 3 study adult comparator group was met No ...
Read moreModerna, Inc. and Aldevron, LLC have announced their expanded collaboration in support of the Moderna COVID-19 Vaccine ...
Read moreModerna and Samsung Biologics announced a Manufacturing Services and Supply Agreement in which Samsung Biologics will ...
Read moreInterim data from Takeda-led Phase 1/2 study indicates immune response consistent with Moderna’s Phase 3 COVE ...
Read moreSingle booster dose of 50 µg of mRNA-1273 or mRNA-1273.351 increased neutralizing titers against SARS-CoV-2 and ...
Read moreModerna, Inc. today announced an expansion of the Moderna Technology Center (MTC) in Norwood, MA, USA including more than doubling ...
Read moreAddress: | Pharma Reg News, First floor, Shop no.1 , Plot no 241,242, Near Fire station, GIDC, Ankleshwar, Gujarat - 393002. |
Phone: | +91 8511586232, +91 9029066605 |
Email: | author@pharmaregnews.com |
© 2021 - Pharmaregnews.com. Developed by YESWEUS.
© 2021 - Pharmaregnews.com. Developed by YESWEUS.